Matthew Keller
Stock Analyst at H.C. Wainwright
(0.07)
# 4,921
Out of 5,189 analysts
113
Total ratings
11.1%
Success rate
-39.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Keller
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KYNB Kyntra Bio | Reiterated: Buy | $43 → $18 | $1.56 | +1,053.85% | 17 | Nov 17, 2026 | |
| LABT Lakewood-Amedex Biotherapeutics | Reiterated: Buy | $3 | $0.2449 | +1,124.99% | 2 | Nov 17, 2026 | |
| GALT Galectin Therapeutics | Reiterated: Buy | $11 | $2.69 | +308.92% | 13 | Nov 16, 2026 | |
| PHIO Phio Pharmaceuticals | Reiterated: Buy | $14 | $0.656 | +2,034.15% | 11 | Nov 16, 2026 | |
| ACXP Acurx Pharmaceuticals | Rated: Buy | $31 → $11 | $1.04 | +957.69% | 14 | Nov 13, 2026 | |
| INKT MiNK Therapeutics | Reiterated: Buy | $38 | $8.02 | +373.82% | 2 | Nov 9, 2026 | |
| GYRE Gyre Therapeutics | Reiterated: Buy | $18 | $4.21 | +327.55% | 13 | Nov 6, 2026 | |
| MCRB Seres Therapeutics | Reiterated: Buy | $12 | $1.24 | +867.74% | 4 | Nov 4, 2026 | |
| IFRX InflaRx | Reiterated: Buy | $8 | $1.04 | +669.23% | 13 | Nov 3, 2026 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterated: Hold | n/a | $0.4682 | - | 6 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.12 | +792.86% | 9 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.000001 | - | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.88 | n/a | 4 | Oct 30, 2025 |
Kyntra Bio
Nov 17, 2026
Reiterated: Buy
Price Target: $43 → $18
Current: $1.56
Upside: +1,053.85%
Lakewood-Amedex Biotherapeutics
Nov 17, 2026
Reiterated: Buy
Price Target: $3
Current: $0.2449
Upside: +1,124.99%
Galectin Therapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $11
Current: $2.69
Upside: +308.92%
Phio Pharmaceuticals
Nov 16, 2026
Reiterated: Buy
Price Target: $14
Current: $0.656
Upside: +2,034.15%
Acurx Pharmaceuticals
Nov 13, 2026
Rated: Buy
Price Target: $31 → $11
Current: $1.04
Upside: +957.69%
MiNK Therapeutics
Nov 9, 2026
Reiterated: Buy
Price Target: $38
Current: $8.02
Upside: +373.82%
Gyre Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $18
Current: $4.21
Upside: +327.55%
Seres Therapeutics
Nov 4, 2026
Reiterated: Buy
Price Target: $12
Current: $1.24
Upside: +867.74%
InflaRx
Nov 3, 2026
Reiterated: Buy
Price Target: $8
Current: $1.04
Upside: +669.23%
60 Degrees Pharmaceuticals
Aug 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.4682
Upside: -
May 14, 2026
Reiterated: Buy
Price Target: $10
Current: $1.12
Upside: +792.86%
Mar 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: -
Oct 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $7.88
Upside: n/a